Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Draper

Showing results (351-360 of 404) with videos related to

Pageof 41
Sort By:
Frontiers in Immunology|March 30, 2018
<i>Plasmodium falciparum</i> Liver Stage Infection and Transition to Stable Blood Stage Infection in Liver-Humanized and Blood-Humanized FRGN KO Mice Enables Testing of Blood Stage Inhibitory Antibodies (Reticulocyte-Binding Protein Homolog 5) <i>In Vivo</i>Lander Foquet, Carola Schafer, Nana K Minkah, et al.
Plos One|September 26, 2014
Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposureSumi Biswas, Prateek Choudhary, Sean C Elias, et al.
Frontiers in Immunology|June 20, 2019
Functional Comparison of Blood-Stage <i>Plasmodium falciparum</i> Malaria Vaccine Candidate AntigensJoseph J Illingworth, Daniel G Alanine, Rebecca Brown, et al.
Scientific Reports|July 27, 2016
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line systemKathryn A Hjerrild, Jing Jin, Katherine E Wright, et al.
Cell Reports. Medicine|March 25, 2021
Protein/AS01<sub>B</sub> vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectorsCarolyn M Nielsen, Ane Ogbe, Isabela Pedroza-Pacheco, et al.
Npj Viruses|May 7, 2026
A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
International Journal for Parasitology|February 4, 2017
Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'Jing Jin, Kathryn A Hjerrild, Sarah E Silk, et al.
Elife|March 2, 2021
Mapping immune variation and <i>var</i> gene switching in naive hosts infected with <i>Plasmodium falciparum</i>Kathryn Milne, Alasdair Ivens, Adam J Reid, et al.
Nature Communications|April 28, 2019
A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primatesAlexander D Douglas, G Christian Baldeviano, Jing Jin, et al.
Nature Microbiology|May 29, 2019
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibodyThomas A Rawlinson, Natalie M Barber, Franziska Mohring, et al.
Pageof 41

Showing results (351-360 of 404) with videos related to

Sort By:
Pageof 41
Frontiers in Immunology|March 30, 2018
<i>Plasmodium falciparum</i> Liver Stage Infection and Transition to Stable Blood Stage Infection in Liver-Humanized and Blood-Humanized FRGN KO Mice Enables Testing of Blood Stage Inhibitory Antibodies (Reticulocyte-Binding Protein Homolog 5) <i>In Vivo</i>Lander Foquet, Carola Schafer, Nana K Minkah, et al.
Plos One|September 26, 2014
Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposureSumi Biswas, Prateek Choudhary, Sean C Elias, et al.
Frontiers in Immunology|June 20, 2019
Functional Comparison of Blood-Stage <i>Plasmodium falciparum</i> Malaria Vaccine Candidate AntigensJoseph J Illingworth, Daniel G Alanine, Rebecca Brown, et al.
Scientific Reports|July 27, 2016
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line systemKathryn A Hjerrild, Jing Jin, Katherine E Wright, et al.
Cell Reports. Medicine|March 25, 2021
Protein/AS01<sub>B</sub> vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectorsCarolyn M Nielsen, Ane Ogbe, Isabela Pedroza-Pacheco, et al.
Npj Viruses|May 7, 2026
A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
International Journal for Parasitology|February 4, 2017
Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'Jing Jin, Kathryn A Hjerrild, Sarah E Silk, et al.
Elife|March 2, 2021
Mapping immune variation and <i>var</i> gene switching in naive hosts infected with <i>Plasmodium falciparum</i>Kathryn Milne, Alasdair Ivens, Adam J Reid, et al.
Nature Communications|April 28, 2019
A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primatesAlexander D Douglas, G Christian Baldeviano, Jing Jin, et al.
Nature Microbiology|May 29, 2019
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibodyThomas A Rawlinson, Natalie M Barber, Franziska Mohring, et al.
Pageof 41